MM Healthcare group or EB generalist programme? (life science background aiming for HC buyside)

I have offers from an MM IB specifically in their healthcare team and an EB but the analyst programme is generalist. I come from an advanced life science degree background and looking to leverage that to aim for HC groups on the buyside whether that is PE or HF. Which of the two would best position me for that? The MM would obviously allow me to gain valuable HC experience but I am hesitant to pigeon hole myself into the MM space and likely close off HFs. Any thoughts appreciated.

18 Comments
 

Top MM HC are Roths and Jef, anything else not worth it but again you'll provably need to lateral elsewhere for top exits. Is the Generalist role with a firm that does rotations / has strong HC practice? If so then take EB (except Moelis) and you can get HC exposure from there and then potentially lateral to HC groups as senior analyst / junior Assoc. Niche buy side roles in life sciences would target HC groups so if that's what you want you need to be at one to have decent chances.

 
Most Helpful

If you're trying to get into HC buyside on the life science side, I'd like to add that MTS Health Partners is worth checking out. I don't think they have any openings yet but a handful of their analysts in recent years have exited to life science buyside.

Always thought very highly of most of the bankers I've interacted there. One of my college buddies runs the commercialization side of his biotech startup and seems to think highly of them (not an official client but has spoken / interacted with MTS before).

 

Consequatur enim nisi quis cupiditate. Dolor eius aperiam est ut iste. Magnam voluptas cum expedita explicabo.

Amet corporis odit veritatis accusamus voluptatibus nulla pariatur. Numquam amet velit quia eaque. Fugit sed reprehenderit rerum laudantium qui aut. Veniam dicta quo ex iusto aperiam et quia. Fugit culpa illum voluptas soluta sint et.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Goldman Sachs 01 97.8%
  • Morgan Stanley 07 97.3%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 98.9%
  • Evercore 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 07 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan No 97.3%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (50) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (26) $182
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”